HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roos, A. Articles by Daha, M. R. Search for Related Content PubMed PubMed Citation Articles by Roos, A. Articles by Daha, M. R.

Specific Inhibition of the Classical Complement Pathway by C1q-Binding Peptides¹

Anja Roos^2,*, Alma J. Nauta^*, Daniël Broers^*, Maria C. Faber-Krol^*, Leendert A. Trouw^*, Jan Wouter Drijfhout and Mohamed R. Daha^*

^* Departments of Nephrology and Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden, The Netherlands

Undesired activation of the complement system is a major pathogenic factor contributing to various immune complex diseases and conditions such as hyperacute xenograft rejection. We aim for prevention of complement-mediated damage by specific inhibition of the classical complement pathway, thus not affecting the antimicrobial functions of the complement system via the alternative pathway and the lectin pathway. Therefore, 42 peptides previously selected from phage-displayed peptide libraries on basis of C1q binding were synthesized and examined for their ability to inhibit the function of C1q. From seven peptides that showed inhibition of C1q hemolytic activity but no inhibition of the alternative complement pathway, one peptide (2J) was selected and further studied. Peptide 2J inhibited the hemolytic activity of C1q from human, chimpanzee, rhesus monkey, rat, and mouse origin, all with a similar dose-response relationship (IC₅₀ 2–6 µM). Binding of C1q to peptide 2J involved the globular head domain of C1q. In line with this interaction, peptide 2J dose-dependently inhibited the binding of C1q to IgG and blocked activation of C4 and C3 and formation of C5b-9 induced via classical pathway activation, as assessed by ELISA. Furthermore, the peptide strongly inhibited the deposition of C4 and C3 on pig cells following their exposure to human xenoreactive Abs and complement. We conclude that peptide 2J is a promising reagent for the development of a therapeutic inhibitor of the earliest step of the classical complement pathway, i.e., the binding of C1q to its target.

This article has been cited by other articles:

				J. Zhang, G. Li, X. Liu, Z. Wang, W. Liu, and X. Ye Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA J. Gen. Virol., November 1, 2009; 90(11): 2751 - 2758. [Abstract] [Full Text] [PDF]

				R. Spirig, C. van Kooten, C. Obregon, L. Nicod, M. Daha, and R. Rieben The Complement Inhibitor Low Molecular Weight Dextran Sulfate Prevents TLR4-Induced Phenotypic and Functional Maturation of Human Dendritic Cells J. Immunol., July 15, 2008; 181(2): 878 - 890. [Abstract] [Full Text] [PDF]

				N. van Montfoort, J. M. H. de Jong, D. H. Schuurhuis, E. I. H. van der Voort, M. G. M. Camps, T. W. J. Huizinga, C. van Kooten, M. R. Daha, J. S. Verbeek, F. Ossendorp, et al. A Novel Role of Complement Factor C1q in Augmenting the Presentation of Antigen Captured in Immune Complexes to CD8+ T Lymphocytes J. Immunol., June 15, 2007; 178(12): 7581 - 7586. [Abstract] [Full Text] [PDF]

				F. D. G. McGrath, M. C. Brouwer, G. J. Arlaud, M. R. Daha, C. E. Hack, and A. Roos Evidence That Complement Protein C1q Interacts with C-Reactive Protein through Its Globular Head Region. J. Immunol., March 1, 2006; 176(5): 2950 - 2957. [Abstract] [Full Text] [PDF]

				T. W. L. Groeneveld, M. Oroszlan, R. T. Owens, M. C. Faber-Krol, A. C. Bakker, G. J. Arlaud, D. J. McQuillan, U. Kishore, M. R. Daha, and A. Roos Interactions of the Extracellular Matrix Proteoglycans Decorin and Biglycan with C1q and Collectins J. Immunol., October 1, 2005; 175(7): 4715 - 4723. [Abstract] [Full Text] [PDF]

				G. Castellano, A. M. Woltman, A. J. Nauta, A. Roos, L. A. Trouw, M. A. Seelen, F. P. Schena, M. R. Daha, and C. van Kooten Maturation of dendritic cells abrogates C1q production in vivo and in vitro Blood, May 15, 2004; 103(10): 3813 - 3820. [Abstract] [Full Text] [PDF]

				U. Kishore, S. K. Gupta, M. V. Perdikoulis, M. S. Kojouharova, B. C. Urban, and K. B. M. Reid Modular Organization of the Carboxyl-Terminal, Globular Head Region of Human C1q A, B, and C Chains J. Immunol., July 15, 2003; 171(2): 812 - 820. [Abstract] [Full Text] [PDF]

				J. M. Inal, M. Pascual, P. Lesavre, and J.-A. Schifferli Complement inhibition in renal diseases Nephrol. Dial. Transplant., February 1, 2003; 18(2): 237 - 240. [Full Text] [PDF]